The eight PALB2-associated breast cancers analyzed by MSK-IMPACT displayed a median of 3 (range 0–5) somatic mutations per case, of which 2 (range 0–4) were non-synonymous (Table 1, Supplementary Table 3). Here, PALB2 is linked to breast carcinoma.